Pulmostics manufacturers breath analysis equipment to diagnose disease. The company's focus is early detection of Sepsis and other diseases.
Pulmostics provides breath analysis tools and services to diagnose disease through analysis of alveolar air. Sepsis, lung cancer, breast cancer, diabetes, leukemia and other diseases have been shown to have a distinctive gas profile in a patients lungs. Pulmostic's initial diagnostic service will be for Sepsis, a hidden killer. Nearly 1.6M people are diagnosed with sepsis annually. 30% die. Sepsis costs about USD 20,000 per patient.